T. Rowe Price Health Sciences Fund ... (THISX)

$87.43

+0.39 (+0.45%)
Rating:
Recommendation:
-
Symbol THISX
Price $87.43
Beta 0.000
Volume Avg. -
Market Cap 14.183B
Shares () -
52 Week Range 78.69-117.24
1y Target Est -
DCF Unlevered THISX DCF ->
DCF Levered THISX LDCF ->
ROE -
ROA -
Operating Margin -
Debt / Equity -
P/E 3.83 Buy
P/B -
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades


None
Nasdaq Capital Market

The investment seeks long-term capital appreciation. The fund will normally invest at least 80% of its net assets (including any borrowings for investment purposes) in the common stocks of companies engaged in the research, development, production, or distribution of products or services related to health care, medicine, or the life sciences (collectively termed "health sciences"). While the fund can invest in companies of any size, the majority of fund assets are expected to be invested in large- and mid-capitalization companies. It is non-diversified.